Door to Needle Time in Acute Ischemic Stroke Patients before and after Initiation of Quality Improvement Project - Single Local Centre Experience

Abstract

Background and Aims: Thrombolysis has been shown to improve stroke outcomes by reducing disability, particularly when administered early. Lowering the door-to-needle time (DNT) for administering intravenous thrombol¬ysis (IVT) is an important objective for improving the quality of acute stroke care. This study aims to compare DNT before and after implementing the code stroke pathway protocol. Methods: The study evaluated the impact of a quality improvement project, Code Stroke, on acute ischemic stroke patients at King Fahd General Hospital in Jeddah, Saudi Arabia, September 2019 to April 2020, using a retrospective record-based analysis, with data extracted using a standardized format and cat¬egorized into pre and post code groups. Results: 81 stroke patients were reviewed, with 47 in the pre-code group and 34 in the post-code group. The re¬ported tPA DNT time was less than 60 minutes in only 8.5% of patients before the implementation of stroke code activation, compared to 55.9% after implementation (p≤.001). Incidence of symptomatic hemorrhagic transformation was 8.6%. Post-code group had a lower median length of hospital stay (8 days) compared to the pre-code (13 days), with a marginal trend towards statistical significance, and half of the post-code group patients had a modified Rankin Scale of 0-2 compared to one third of the pre-code group at three months of discharge. Conclusions: The Code Stroke project resulted in a significant reduction in DNT, improved functional outcomes, and a reduction in hospital length of stay, but the incidence of symptomatic intracranial hemorrhage and in-hospital mortality rates were slightly higher than expected, requiring continued improvement efforts.

References

1. 1.Global,regional,andnationalburdenof stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021, 20:795-820. 10.1016/ S1474-4422(21)00252-0 .
2. 2.Werner Hacke , Geoffrey Donnan, Cesare Fieschi, Markku Kaste, Rüdiger von Kummer, Joseph P Brodericket al. Association of outcome with early stroketreatment:pooledanalysisofAT- LANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768–74.
3. 3.Jeffrey L. Saver, MD; Gregg C. Fonarow, MD; Eric E. Smith, MD, MPH; et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013; 309:2480–8.
4. 4.Ali M Al Khathaami , Bayan Al Bdah , Maisoun Tarawneh , Mohammed Alskaini , Faris Alotaibi, Abdulaziz Alshalan, et al. Utilization of IntravenousTissue PlasminogenActivator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia, J Stroke Cerebrovasc Dis, 2020 May;29(5):104761. doi: 10.1016/j.jstrokecerebrovasdis.2020.104761. Epub 2020 Mar 12. doi:10.1016/j.jstrokecerebrovasdis.2020.104761
5. 5.Kruyt ND, Nederkoorn PJ, Dennis M, Leys D, Ringleb PA, Rudd AG, et al. Door-to-needle time and the proportion of patients receiving intravenous thrombolysis in acute ischemic stroke: uniform interpretation and reporting. Stroke. 2013;44(11):3249–53.
6. 6.Kuhrij, L.S., Marang-van de Mheen, P.J., van den Berg-Vos, R.M. et al. Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit. BMC Neurol 19, 265 (2019). https:// doi.org/10.1186/s12883-019-1512-2. doi:10.1186/s12883-019-1512-2
7. 7.Edward C Jauch, Jeffrey L Saver, Harold PAdams Jr,Askiel Bruno, J J Buddy Connors, Bart M Demaerschalk et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare pro- Majmaah Journal of Health Sciences ,Vol. 11, Issue 4 , October - 2023, Rabi’Al-Awwal - 1445 95 Door To Needle Time inAcute Ischemic Stroke Patients before and after Initiation of Quality Improvement Project - Single Local Centre Experience fessionals from theAmerican heartAssociation/American stroke association. Stroke 2013;44:870–947.
8. 8.Olson DM, Constable M, Britz GW, Lin CB, Zimmer LO, Schwamm LH, Fonarow GC, Peterson ED. A qualitative assessment of practices associated with shorter door-to-needle time for thrombolytic therapy in acute ischemic stroke. Journal of Neuroscience Nursing. 2011 Dec 1;43(6):329-36.